SynthesisBMC pediatrics2025
Pediatric rhabdomyolysis: a systematic review and meta-analysis of etiologies, management, and outcomes.
Synthesis in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRhabdomyolysis is a potentially fatal disorder that occurs due to various causes. Therefore, the aim of this meta-analysis was to identify the underlying causes, evaluate the treatment options, and determine the mortality and kidney outcomes of children with rhabdomyolysis.
methodsWe comprehensively searched PubMed, Cochrane Library, Web of Science, EMBASE, and Google Scholar databases for records written in English and published until April 2025. According to PICO criteria, we included studies that enrolled pediatric patients with rhabdomyolysis and reported etiologies, treatments, mortality, and/or kidney outcomes. Subsequently, quality appraisal was conducted with Newcastle Ottawa Scale and statistical analyses were performed using comprehensive meta-analysis (CMA) software.
resultsFifteen studies enrolling 10,514 pediatric patients with rhabdomyolysis were reviewed and analyzed. The one-arm meta-analysis revealed that infections were the most predominant etiology of rhabdomyolysis (40.6%; 95% CI: 33.5 to 48.2), followed by trauma (19%; 95% CI: 15.5 to 23.0) and exercise (14.7%; 95% CI: 6.5 to 30.2). Other etiologies accounted for less than 10% of rhabdomyolysis cases i.e., burns (2.9%; 95% CI: 1.2 to 7.2), connective tissue disorder (2.7%; 95% CI: 0.7 to 9.6), drugs (5.8%; 95% CI: 3.1 to 10.6), metabolic abnormalities (4.4%; 95% CI: 3.0 to 6.6), multiorgan failure (4.1%; 95% CI: 1.0 to 15.5), muscular dystrophy (2.6%; 95% CI: 0.6 to 11.4), seizure (7.2%; 95% CI: 3.9 to 12.9), and sepsis (9.9%; 95% CI: 1.1 to 52.8). The pooled results also showed that the incidences of acute kidney injury (AKI) and chronic kidney disease (CKD) were 21.3% (95% CI: 14.5 to 30.3; I
conclusionsInfections are the leading causes of rhabdomyolysis in children. Moreover, AKI is a common complication of rhabdomyolysis in children. However, the prognosis of children with rhabdomyolysis is good and few patients progress to CKD. SYSTEMATIC REVIEW PROTOCOL REGISTRATION: PROSPERO: CRD420251035968.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.